FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 5, 1999
---------------------------------------
HELIX BIOMEDIX, INC.
(Exact name of registrant as specified in its charter)
CO NO 33-20897-D 84-1080717
(State or other jurisdiction (Commission File Number) (I. R. S. Employer
of incorporation) Identification No.)
2151 E. Lakeshore Drive, Baton Rouge, LA 70808
(Address of principal executive offices) (Zip code)
(225) 387-1112
(Registrant's telephone number, including area code)
<PAGE>
Item 1. Changes in Control of Registrant.
On October 5, 1999, the Company consummated a private placement of equity
securities with a limited number of investors, resulting in the purchase and
sale of 2,728,143 shares of the Company's common stock and warrants entitling
the holders of each such share to purchase an additional share of common
stock at a price of $3.25 per share. Immediately prior to the closing of the
offering, Keith P. Lanneau was the beneficial owner of approximately 51.7% of
all issued and outstanding shares of common stock. Immediately following the
closing, Keith P. Lanneau was the beneficial owner of approximately 19.4%,
and Frank T. Nickell was the beneficial owner of approximately 10.1%, of all
issued and outstanding shares of common stock (without giving effect to
outstanding options and convertible securities). No other person owns more
than 10% of the issued and outstanding stock.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HELIX BIOMEDIX, INC.
Date: October 20, 1999
Keith P. Lanneau, Chairman
